An Australian Patent Journal Round-Up 13 September 2012.

An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 13 September 2012.

 

Opposition Proceedings

Opposition Lodged

No new opposition proceedings have been filed as at 13 September 2012.

 

Opposition Withdrawn

Opposition to acceptance of the following applications has been withdrawn as at 13 September 2012, and the application shall proceed to sealing:

Application No.

Applicant(s)

Opponent(s)

2007233252 Merial Limited Intervacc AB

 

Applications Withdrawn

The following applications have been withdrawn following opposition as at 13 September 2012:

Application No.

Applicant(s)

Opponent(s)

2006239738 Scantech International Pty Ltd RTI Pty Ltd

 

Opposition Dismissed

No additional opposition proceedings have been dismissed as at 13 September 2012.

 

Extensions of Term of Standard Patents

Applications Filed

The following application(s) for Extension of Term under Section 70 have been made as at 13 September 2012:

Patent No.

Patentee(s)

Goods & 1st Reg. Approval

2001288318 Vertex Pharmaceuticals Incorporated INCIVO telaprevir; 6 March 2012
2002255220 Nycomed Pharma AS TACHOSIL human fibrinogen and human thrombin; 22 March 2012
2004204381 Archimedes Development Limited PECFENT fentanyl (as fentanyl citrate); 13 August 2012
779303 Regeneron Pharmaceuticals, Inc. EYLEA aflibercept (rch)

 

Surrendered and Revoked Letters Patent

Surrendered Letters Patent

No additional patents have been offered for surrender as at 13 September 2012.

 

Revocation of Letters Patent

The following patents have wholly or partially been revoked as at 13 September 2012:

Patent No.

Patentee(s)

Date of Patent & Title

Details

2011100773 Blades, D. 2 February 2012;

A method and system to edit textual information on a mobile device in creating a message for transmission as a multimedia message within a cellular network

Patentee offered to surrender the Patent, as advertised in Patents Journal dated 19 July 2012; Patent revoked in accordance with s 137.
676571 Pfizer Ireland Pharmaceuticals 13 May 1994; Pyrazolopyrimidinones for the treatment of impotence Pursuant to an Order of the Federal Court (No VID 604 of 2005) of Justice Heerey dated 11 March 2005; claim 10 has been revoked.